Creb1-Mecp2-mCpG complex transactivates postnatal murine neuronal glucose transporter isoform 3 expression

Endocrinology

Volumn 154, Issue 4, 2013, Pages 1598-1611

  Chen, Yongjun ^a,b   Shin, Bo Chul ^a   Thamotharan, Shanthie ^a   Devaskar, Sherin U ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c MDCC 22 402 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA METHYLTRANSFERASE 3A; GLUCOSE TRANSPORTER 4; HISTONE DEACETYLASE 1; METHYL CPG BINDING PROTEIN 2; SMALL INTERFERING RNA; TRICHOSTATIN A;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DEPOLYMERIZATION; DNA FLANKING REGION; DNA METHYLATION; GENE IDENTIFICATION; HIPPOCAMPUS; INHIBITION KINETICS; MOUSE; NONHUMAN; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANSACTIVATION; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; CPG ISLANDS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA METHYLATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOSE TRANSPORTER TYPE 3; METHYL-CPG-BINDING PROTEIN 2; MICE; TRANS-ACTIVATORS;

EID: 84875818042     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2076     Document Type: Article

References (47)

1. Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab. 2007;27:1766-1791.
2. Simpson IA, Dwyer D, Malide D, Moley KH, Travis A, Vannucci SJ. The facilitative glucose transporter GLUT3: 20 years of distinction. Am J Physiol Endocrinol Metab. 2008;295:E242-E253.
3. Mantych GJ, James DE, Chung HD, Devaskar SU. Cellular localization and characterization of Glut 3 glucose transporter isoform in human brain. Endocrinology. 1992;131:1270-1278.
4. Fields HM, Rinaman L, Devaskar SU. Distribution of glucose transporter isoform-3 and hexokinase I in the postnatal murine brain. Brain Res. 1999;846:260-264.
5. Khan JY, Rajakumar RA, McKnight RA, Devaskar UP, Devaskar SU. Developmental regulation of genes mediating murine brain glucose uptake. Am J Physiol. 1999;276:R892-900.
6. Thamotharan S, Stout D, Shin BC, Devaskar SU. Temporal and spatial distribution of murine placental and brain Glut3-luciferase transgene as a read out of in-vivo transcription. Am J Physiol Endocrinol Metab. 2013;304:E254-E266.
7. Rajakumar RA, Thamotharan S, Menon RK, Devaskar SU. Sp1 and Sp3 regulate transcriptional activity of the facilitative glucose transporter isoform-3 gene in mammalian neuroblasts and trophoblasts. J Biol Chem. 1998;273:27474-27483.
8. Rajakumar A, Thamotharan S, Raychaudhuri N, Menon RK, Devaskar SU. Trans-activators regulating neuronal glucose transporter isoform-3 gene expression in mammalian neurons. J Biol Chem. 2004;279:26768-26779.
9. Devaskar SU, Raychaudhuri S. Epigenetics-a science of heritable biological adaptation. Pediatr Res. 2007;61:1R-4R.
10. Raychaudhuri N, Raychaudhuri S, Thamotharan M, Devaskar SU. Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring. J Biol Chem. 2008; 283:13611-13626.
11. Li Y, Maher P, Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron. 1997;19:453-463.
12. Yu S, Zhang JZ, Zhao CL, Zhang HY, Xu Q. Isolation and characterization of the CD133+precursors from the ventricular zone of human fetal brain by magnetic affinity cell sorting. Biotechnol Lett. 2004;26:1131-1136.
13. Suo Z, Wu M, Citron BA, Palazzo RE, Festoff BW. Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling. J Biol Chem. 2003;278:37681-37689.
14. Lo PK, Watanabe H, Cheng PC, et al. MethySYBR, a novel quantitative PCR assay for the dual analysis of DNA methylation and CpG methylation density. J Mol Diagn. 2009;11:400-414.
15. Hattermann K, Mehdorn HM, Mentlein R, Schultka S, Held-Feindt J. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis. Anal Biochem. 2008; 377:62-71.
16. Geisberg JV, Struhl K. Quantitative sequential chromatin immunoprecipitation, a method for analyzing co-occupancy of proteins at genomic regions in vivo. Nucleic Acids Res. 2004;32:e151.
17. Furlan-Magaril M, Rincon-Arano H, Recillas-Targa F. Sequential chromatin immunoprecipitation protocol: ChIP-reChIP. Methods Mol Biol. 2009;543:253-266.
18. Irvine RA, Hsieh CL. Q-PCR in combination with ChIP assays to detect changes in chromatin acetylation. Methods Mol Biol. 2004; 287:45-52.
19. Shin BC, Dai Y, Thamotharan M, Gibson LC, Devaskar SU. Preand postnatal calorie restriction perturbs early hypothalamic neuropeptide and energy balance. J Neurosci Res. 2012;90:1169-1182.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods. 2001;25:402-408.
21. Kudo S, Nomura Y, Segawa M, et al. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems. Brain Dev. 2001;23(suppl 1):S165-S173.
22. Gonzalez GA, Montminy MR. CyclicAMPstimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 1989;59:675-680.
23. Shin BC, Fujikura K, Suzuki T, Tanaka S, Takata K. Glucose transporter GLUT3 in the rat placental barrier: a possible machinery for the transplacental transfer of glucose. Endocrinology. 1997;138: 3997-4004.
24. Ganguly A, McKnight RA, Raychaudhuri S, Shin BC, Ma Z, Moley K, Devaskar SU. Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction. Am J Physiol Endocrinol Metab. 2007;292:E1241-E1255.
25. Chahrour M, Jung SY, Shaw C, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008;320:1224-1229.
26. Innocenti GM. Development and evolution: two determinants of cortical connectivity. Prog Brain Res. 2011;189:65-75.
27. Geschwind DH. Advances in autism. Annu Rev Med. 2009;60:367-380.
28. Zhao Y, Fung C, Shin D, et al. Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders. Mol Psychiatry. 2010;15:286-299.
29. Chen RZ, Akbarian S, Tudor M, Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet. 2001;27:327-331.
30. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet. 2001;27:322-326.
31. Geschwind DH, Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol. 2007;17:103-111.
32. Toal F, Murphy DG, Murphy KC. Autistic-spectrum disorders: lessons from neuroimaging. Br J Psychiatry. 2005;187:395-397.
33. Haznedar MM, Buchsbaum MS, Wei TC, et al. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am J Psychiatry. 2000;157:1994-2001.
34. Haznedar MM, Buchsbaum MS, Hazlett EA, LiCalzi EM, Cartwright C, Hollander E. Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiatry. 2006;163:1252-1263.
35. Thoidis G, Kupriyanova T, Cunningham JM, et al. Glucose transporter Glut3 is targeted to secretory vesicles in neurons and PC12 cells. J Biol Chem. 1999;274:14062-14066.
36. Villemagne PM, Naidu S, Villemagne VL, et al. Brain glucose metabolism in Rett syndrome. Pediatr Neurol. 2002;27:117-122.
37. Naidu S, Kaufmann WE, Abrams MT, et al. Neuroimaging studies in Rett syndrome. Brain Dev. 2001;23(suppl 1):S62-S71.
38. Kishi N, Macklis JD. MECP2 is progressively expressed in postmigratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci. 2004;27:306-321.
39. Belichenko PV, Wright EE, Belichenko NP, et al. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol. 2009;514:240-258.
40. Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 2009;8:1056-1072.
41. Hite KC, Adams VH, Hansen JC. Recent advances in MeCP2 structure and function. Biochem Cell Biol. 2009;87:219-227.
42. Bogdanovic O, Veenstra GJ. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma. 2009;118:549-565.
43. Nonaka M. A Janus-like role of CREB protein: enhancement of synaptic property in mature neurons and suppression of synaptogenesis and reduced network synchrony in early development. J Neurosci. 2009;29:6389-6391.
44. Pescucci C, Meloni I, Bruttini M, et al. Chromosome 2 deletion encompassing the MAP2 gene in a patient with autism and Rett-like features. Clin Genet. 2003;64:497-501.
45. Dekker FJ, Haisma HJ. Histone acetyl transferases as emerging drug targets. Drug Discov Today. 2009;14:942-948.
46. Wirtz S, Schuelke M. Region-specific expression of mitochondrial complex I genes during murine brain development. PLoS One. 2011;6:e18897.
47. Finlay BL, Darlington RB. Linked regularities in the development and evolution of mammalian brains. Science. 1995;268:1578-1584.